Fact check · Version 1 · Sources checked
“Bremelanotide is FDA-approved for a specific form of HSDD.”
The Peptide Field explains research. Its pages are not independently medically reviewed, and they do not diagnose, prescribe, or recommend treatment.
Supported with scope
The reviewed evidence supports this exact statement only in the situation described below.
Vyleesi is approved for acquired, generalized HSDD in certain premenopausal women after specified exclusions.
- What this answer is based on
- This answer uses an official regulator record or a specific product label.
- Limits of this answer
- The population and limitations in the current Vyleesi label. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.
- Topic
- Whether a specific product has an approval or another official status.
Sources for this fact check
Show 1 sources
- Sources checked by
- Site editor · Editorial review